US 11839604
Use of sublingual dexmedetomidine for the treatment of agitation
granted A61KA61K31/4174A61K45/06
Quick answer
US patent 11839604 (Use of sublingual dexmedetomidine for the treatment of agitation) held by BioXcel Therapeutics, Inc. expires Mon Dec 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BioXcel Therapeutics, Inc.
- Grant date
- Tue Dec 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/4174, A61K45/06, A61K47/10, A61K9/006